KemPharm (KMPH) Misses Q3 EPS by 26c
Tweet
Share
E-mailGet Alerts KMPH Hot Sheet
Join SI Premium – FREE
KemPharm (NASDAQ: KMPH) reported Q3 EPS of ($0.68), $0.26 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on KemPharm (KMPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nike (NKE) Tops Q1 EPS by 4c
- Bernstein SocGen on nVent Electric (NVT): 'Our Top Pick Going into 3Q (across our entire coverage)'
- Raymond James Reiterates Market Perform Rating on Comcast Corp (CMCSA)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
